Back

Evaluation of naples prognostic score to predict long-term mortality in patients with pulmonary embolism

2 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Venous thromboembolism: international perspectives Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tugba Cetin

Istanbul (Turkiye)

9 More presentations in this session

Presentation thumbnail
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.
Doctor A. Mamzer (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
A novel dynamic risk score to predict Clinically Significant Bleeding (CSB) after 3 months of anticoagulation in patients with incident Venous ThromboEmbolism (VTE) and without active cancer.
Doctor A. Cohen (London, GB)
Abstract Slides Video
Presentation thumbnail
Validation of the PESI-Echo score: as a prognostic tool for mortality in acute pulmonary thromboembolism in Mexican population.
Slides Video
Presentation thumbnail
Sex differences in in-hospital management and outcomes of patients with acute pulmonary embolism
Professor C. Becattini (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Venous thromboembolism: international perspectives

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Parameters for better stratifying intermediate-high risk patients affected by acute pulmonary embolism
thumbnail
Congress Presentation
Prognostic value of the echocardiographic ratio tricuspid annular plane systolic excursion / pulmonary arterial systolic pressure in acute pulmonary embolism
thumbnail
Congress Presentation
Factors of unfavorable prognosis in patients with non-high risk pulmonary embolism

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources